Due to the improved public perception of clinical trials and local investment in clinical research, Ukraine has become an attractive destination for global investment. As a result, over 550 Phase I-III clinical trials are being currently conducted in the country. To help attract further investment in Ukraine from global pharmaceutical companies, FutureMeds will continue to support the industry, help to raise standards and improve trial efficiency.
Dr. Ivan Vyshnyvetskyy, MD, PhD, with over 20 years experience in conducting sponsored clinical trials as an Investigator, will be leading FutureMeds’ Ukrainian operations and extending FutureMeds' Dedicated Research Sites Network into Ukraine. He assumed Managing Director responsibilities on 1st October 2021.
“I really enjoy working with Ivan and admire his knowledge and enthusiasm. He is a great fit for FutureMeds’ management team. Ukraine is an important market for clinical research and our presence in this country is a cornerstone of our expansion strategy.“
- Dr. Radoslaw Janiak, CEO of FutureMeds
FutreMeds entry to Ukraine opens one of the largest populations in Europe to clinical trials. FutureMeds’ quality standards and 4 times more efficient trial process in combination with access to primary and secondary care patients in Ukraine create a unique opportunity to support faster development of new drugs to market.
Leading FutureMeds’ Dedicated Research Site Network in Ukraine, Dr. Vyshnyvetskyy will continue raising public awareness of clinical trials, increase trial efficiency and extend trial opportunities in the country.
Dr. Vyshnyvetskyy holds a Ph.D. degree in Cardiology and Associate Professorship in Internal Medicine. Prior to joining FutureMeds, Ivan worked as Head of Clinical Trial Administration Unit at Donetsk National Medical University until 2014.
Between 2014 and 2016, as a Head of Department, he helped to grow Universal Clinic "Oberig", a multidisciplinary medical centre in Kyiv, Ukraine. In 2016 Dr. Vyshnyvetskyy started a small Site Service Organization, which supports the operations of Ukrainian sites in different therapeutic areas.
Since 2014 he has been also working as an Associate Professor of Healthcare Management Department of Bogomolets National Medical University in Kyiv, Ukraine and is mentoring the course “Basics of biomedical research” for postgraduates.
In 2018 as part of a group of research doctors and others working in the field he established the Ukrainian Association for Clinical Research NGO. As the president of the NGO, he ensures that the organisation stays on mission, protects the rights of research doctors, continues to harmonise legislation, increases cooperation with the Ukrainian regulatory body and promotes the development of clinical research in the country.
“Ukraine is a great place to conduct clinical trials with lots of opportunities for growth. FutureMeds is a great company with exciting aspirations and a leadership team of unprecedented experience to unleash that potential. I am happy to join the company on its thrilling journey.“ commented Dr. Ivan Vyshnyvetskyy, MD, PhD.
FutureMeds is solely focused on clinical trials resulting in a higher number of patients with enhanced data quality which enables trials to be concluded faster. Opening the first FutureMeds site in Ukraine is the next significant step towards helping their clients worldwide make the clinical trial process more patient-centric and efficient.
FutureMeds is a fast-growing independent Dedicated Research Site Network supporting pharmaceutical companies, Sponsors and CROs and contributing to research to find effective treatments and medications for all patients who need them.
FutureMeds’ Dedicated Research Site teams strive to accelerate study timelines, streamline processes, lower costs and improve data quality to help accelerate patient access to new treatments.
Through acquisitions and a strategic focus on patient experience, FutureMeds has developed qualified patient pools across Europe that enables faster patient enrollment and strong retention and help generate more accurate results.
Follow us on LinkedIn
Follow FutureMeds on LinkedIn and join a growing group of engaged, passionate healthcare and pharmaceutical professionals who are on a mission to accelerate the drug development process and achieve regulatory approval faster so patients can safely access the very latest treatments as soon as possible.